Jindal Drugs Pvt Ltd
Next 500 2015
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#335(2015)
#335(2015)
Financial Data 2020
Revenue
406
(INR Cr)
Net Operating Income
314
(INR Cr)
Assets
1,403
(INR Cr)
Profit
90
(INR Cr)
Net Worth
1,207
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 406 6.6% | 381 -27.7% | 527 65.3% | 319 -6.8% | 342 -65.1% | 979 0.2% | 978 -0.3% | 981 -14.3% | 1144 153.7% | 451 -20.1% | 564 49.6% | 377 - |
| Net Operating Income (INR Cr) | 314 -7.59% | 340 -15.13% | 400 25.45% | 319 2.62% | 311 -64.11% | 873 -7.12% | 940 0.00% | 955 -13.27% | 1101 165.86% | 414 -22.70% | 536 47.29% | 364 -46.69% |
| Profit (INR Cr) | 90 -19.0% | 111 -23.6% | 145 258.3% | 41 -0.5% | 41 -22.5% | 53 -44.5% | 95 -18.3% | 116 64.4% | 71 237.2% | 21 -54.5% | 46 84.2% | 25 - |
| Assets (INR Cr) | 1403 20.8% | 1161 3.1% | 1126 29.7% | 869 -22.3% | 1119 2.9% | 1087 5.9% | 1026 24.1% | 827 24.2% | 666 14.2% | 583 0.8% | 578 26.3% | 458 - |
| Net Worth (INR Cr) | 1207 8.1% | 1116 11.0% | 1006 16.9% | 860 -10.4% | 960 17.0% | 941 8.3% | 868 0.0% | 673 20.8% | 557 14.5% | 486 4.5% | 465 11.0% | 419 5.2% |
| Employee Cost (INR Cr) | 6 -2.8% | 6 10.2% | 6 240.7% | 2 129.3% | 1 -96.2% | 19 -5.4% | 21 175.1% | 7 51.4% | 5 59.9% | 3 10.0% | 3 -13.8% | 3 - |
| Interest Cost (INR Cr) | 5 | 2 | 3 | 2 | 4 | 6 | 21 | 11 | 36 | 2 | 1 | 0 |
| Cash & Bank Balance (INR Cr) | 757 | 588 | 389 | 173 | 229 | 38 | 101 | 217 | 205 | 241 | 214 | 92 |
| Total Debt (INR Cr) | 196 | 44 | 120 | 8 | 158 | 143 | 155 | 152 | 108 | 97 | 113 | 39 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 22.1% | 29.2% | 27.6% | 12.7% | 11.9% | 5.4% | 9.7% | 11.8% | 6.2% | 4.6% | 8.1% | 6.6% |
| Profit As % Of Assets | 6.4% | 9.6% | 12.9% | 4.7% | 3.7% | 4.8% | 9.2% | 14.0% | 10.6% | 3.6% | 7.9% | 5.5% |
| Profit As % Of Networth | 7.5% | 9.9% | 14.5% | 4.7% | 4.3% | 5.6% | 10.9% | 17.3% | 12.7% | 4.3% | 9.9% | 6.0% |
| Interest Cost to EBITDA % | 7.4% | 1.8% | 3.3% | 7.2% | 8.4% | 12.4% | 15.2% | 8.1% | 33.0% | 40.0% | 3.5% | - |
| Debt to Equity Ratio | 0.16 | 0.04 | 0.12 | 0.01 | 0.16 | 0.15 | 0.18 | 0.23 | 0.19 | 0.20 | 0.24 | 0.09 |
| RONW | 7.7% | 10.5% | 14.0% | 4.5% | 4.0% | 5.8% | 10.9% | 18.9% | 13.5% | 4.4% | 9.9% | 6.1% |
| ROCE | 9.7% | 12.7% | 17.0% | 5.0% | 4.3% | 6.8% | 13.7% | 21.1% | 19.8% | 5.0% | 9.7% | 5.6% |